Schedule 13D ownership disclosure
PROVECTUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 74373F100
Event date: 2017-03-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.5400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-102259
- Form type
- SC 13D
- Filer
- MILLER COURTLANDT G
- CIK
- CIK 901585
- Filed
- Mar 30, 2017
- Reporting period
- Mar 19, 2017
- Description
- Schedule 13D beneficial ownership